Zetian Zheng

Zetian Zheng

Auto-generated profile, based on publicly available information

Zetian Zheng

City University of Hong Kong

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2023 in Advanced Science
Verified
Journal Article
Open access
ZZZetian Zheng
Zetian Zheng
JCJunyi Chen
Junyi Chen
XCXingjian Chen
Xingjian Chen
LHLei Huang
Lei Huang
WXWeidun Xie
Weidun Xie
Ka-Chun WongKa-Chun Wong
Ka-Chun Wong
The single‐cell RNA sequencing (scRNA‐seq) quantifies the gene expression of individual cells, while the bulk RNA sequencing (bulk RNA‐seq) characterizes the mixed transcriptome of cells. The inference of drug sensitivities for individual cells can provide new insights to understand the mechanism of anti‐cancer response heterogeneity and drug resistance at the cellular resolution. However, pharmacogenomic information related to their corresponding scRNA‐Seq is often limited. Therefore, a transfer learning model is proposed to infer the drug sensitivities at single‐cell level. This framework learns bulk transcriptome profiles and pharmacogenomics information from population cell lines in a large public dataset and transfers the knowledge to infer drug efficacy of individual cells. The results suggest that it is suitable to learn knowledge from pre‐clinical cell lines to infer pre‐existing cell subpopulations with different drug sensitivities prior to drug exposure. In addition, the model offers a new perspective on drug combinations. It is observed that drug‐resistant subpopulation can be sensitive to other drugs (e.g., a subset of JHU006 is Vorinostat‐resistant while Gefitinib‐sensitive); such finding corroborates the previously reported drug combination (Gefitinib + Vorinostat) strategy in several cancer types. The identified drug sensitivity biomarkers reveal insights into the tumor heterogeneity and treatment at cellular resolution.

27 March 2024 in Briefings in Bioinformatics
Verified
Journal Article
Open access
PDF file
LMLingkuan Meng
Lingkuan Meng
XCXingjian Chen
Xingjian Chen
Ke ChengKe Cheng
Ke Cheng
NCNanjun Chen
Nanjun Chen
ZZZetian Zheng
Zetian Zheng
Ka-Chun WongKa-Chun Wong
Ka-Chun Wong
Protein acetylation is one of the extensively studied post-translational modifications (PTMs) due to its significant roles across a myriad of biological processes. Although many computational tools for acetylation site identification have been developed, there is a lack of benchmark dataset and bespoke predictors for non-histone acetylation site prediction. To address these problems, we have contributed to both dataset creation and predictor benchmark in this study. First, we construct a non-histone acetylation site benchmark dataset, namely NHAC, which includes 11 subsets according to the sequence length ranging from 11 to 61 amino acids. There are totally 886 positive samples and 4707 negative samples for each sequence length. Secondly, we propose TransPTM, a transformer-based neural network model for non-histone acetylation site predication. During the data representation phase, per-residue contextualized embeddings are extracted using ProtT5 (an existing pre-trained protein language model). This is followed by the implementation of a graph neural network framework, which consists of three TransformerConv layers for feature extraction and a multilayer perceptron module for classification. The benchmark results reflect that TransPTM has the competitive performance for non-histone acetylation site prediction over three state-of-the-art tools. It improves our comprehension on the PTM mechanism and provides a theoretical basis for developing drug targets for diseases. Moreover, the created PTM datasets fills the gap in non-histone acetylation site datasets and is beneficial to the related communities. The related source code and data utilized by TransPTM are accessible at https://www.github.com/TransPTM/TransPTM.

26 April 2022 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
WXWeidun Xie
Weidun Xie
ZZZetian Zheng
Zetian Zheng
WZWeitong Zhang
Weitong Zhang
LHLei Huang
Lei Huang
QLQiuzhen Lin
Qiuzhen Lin
Ka-Chun WongKa-Chun Wong
Ka-Chun Wong
Targeted therapy for one for a set of genes has made it possible to apply precision medicine for different patients due to the existence of tumor heterogeneity. However, how to regulate those genes are still problematic. One of the natural regulators of genes is microRNAs. Thus, a better understanding of the miRNA-gene interaction mechanism might contribute to future diagnosis, prevention, and cancer therapy. The interactions between microRNA and genes play an essential role in molecular genetics. The in-vivo experiments validating the relationships between them are time-consuming, money-costly, and labor-intensive. With the development of high-throughput technology, we dealt with tons of biological data. However, extracting features from tremendous raw data and making a mathematical model is still a challenging topic. Machine learning and deep learning algorithms have become powerful tools in dealing with biological data. Inspired by this, in this paper, we propose a model that combines features/embedding extraction methods, deep learning algorithms, and a voting system. We leverage doc2vec to generate sequential embedding from molecular sequences. The role2vec, GCN, and GMM for geometrical embedding were generated from the complex network from similarity and pair-wise datasets. For the deep learning algorithms, we leveraged LSTM and Bi-LSTM according to different embedding and features. Finally, we adopted a voting system to balance results from different data sources. The results have shown that our voting system could achieve a higher AUC than the existing benchmark. The case studies demonstrate that our model could reveal potential relationships between miRNAs and genes. The source code, features, and predictive results can be downloaded at https://github.com/Xshelton/SRG-vote .

3 June 2024 in Bioinformatics
Verified
Journal Article
Open access
PDF file
XCXingjian Chen
Xingjian Chen
JLJiecong Lin
Jiecong Lin
YWYuchen Wang
Yuchen Wang
WZWeitong Zhang
Weitong Zhang
WXWeidun Xie
Weidun Xie
Ka-Chun WongKa-Chun Wong
Ka-Chun Wong
Motivation: Tissue context and molecular profiling are commonly used measures in understanding normal development and disease pathology. In recent years, the development of spatial molecular profiling technologies (e.g. spatial resolved transcriptomics) has enabled the exploration of quantitative links between tissue morphology and gene expression. However, these technologies remain expensive and time-consuming, with subsequent analyses necessitating high-throughput pathological annotations. On the other hand, existing computational tools are limited to predicting only a few dozen to several hundred genes, and the majority of the methods are designed for bulk RNA-seq. Results: In this context, we propose HE2Gene, the first multi-task learning-based method capable of predicting tens of thousands of spot-level gene expressions along with pathological annotations from H&E-stained images. Experimental results demonstrate that HE2Gene is comparable to state-of-the-art methods and generalizes well on an external dataset without the need for re-training. Moreover, HE2Gene preserves the annotated spatial domains and has the potential to identify biomarkers. This capability facilitates cancer diagnosis and broadens its applicability to investigate gene-disease associations. Availability and implementation: The source code and data information has been deposited at https://github.com/Microbiods/HE2Gene.

3 July 2023 in Bioinformatics
Verified
Journal Article
Open access
PDF file
JYJixiang Yu
Jixiang Yu
NCNanjun Chen
Nanjun Chen
ZZZetian Zheng
Zetian Zheng
MGMing Gao
Ming Gao
NLNing Liang
Ning Liang
Ka-Chun WongKa-Chun Wong
Ka-Chun Wong
Motivation: Chromothripsis, associated with poor clinical outcomes, is prognostically vital in multiple myeloma. The catastrophic event is reported to be detectable prior to the progression of multiple myeloma. As a result, chromothripsis detection can contribute to risk estimation and early treatment guidelines for multiple myeloma patients. However, manual diagnosis remains the gold standard approach to detect chromothripsis events with the whole-genome sequencing technology to retrieve both copy number variation (CNV) and structural variation data. Meanwhile, CNV data are much easier to obtain than structural variation data. Hence, in order to reduce the reliance on human experts’ efforts and structural variation data extraction, it is necessary to establish a reliable and accurate chromothripsis detection method based on CNV data. Results: To address those issues, we propose a method to detect chromothripsis solely based on CNV data. With the help of structure learning, the intrinsic relationship-directed acyclic graph of CNV features is inferred to derive a CNV embedding graph (i.e. CNV-DAG). Subsequently, a neural network based on Graph Transformer, local feature extraction, and non-linear feature interaction, is proposed with the embedding graph as the input to distinguish whether the chromothripsis event occurs. Ablation experiments, clustering, and feature importance analysis are also conducted to enable the proposed model to be explained by capturing mechanistic insights. Availability and implementation: The source code and data are freely available at https://github.com/luvyfdawnYu/CNV_chromothripsis.

24 June 2025
Verified
Book Chapter
Closed access
PDF file
YWYuchen Wang
Yuchen Wang
XCXingjian Chen
Xingjian Chen
ZZZetian Zheng
Zetian Zheng
WXWeidun Xie
Weidun Xie
FWFuzhou Wang
Fuzhou Wang
Ka-Chun WongKa-Chun Wong
Ka-Chun Wong